Search by Medical Condition
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for Parkinsonian Disorders
- AMX0035 and Progressive Supranuclear Palsy
- Biomarker Validation Following Sargramostim Treatment in Parkinson's Disease
- MIBG in Aging and Neurologic Disorders
- Efficacy and Safety of Astragalus for Non-motor Symptoms of Parkinsonism
- Role and Mechanism of Probiotics in Improving Motor Symptoms in Mild to Moderate Parkinson's Disease
- Use of Accelerometer for Quantification of Neurogenic Orthostatic Hypotension Symptoms
- A Study to Evaluate the Diagnostic Efficacy of DaTSCAN™ Ioflupane (123I) Injection in Single Photon Emission Computed Tomography (SPECT) for the Diagnosis of Parkinsonian Syndrome (PS) in Chinese Patients
- Trial of Parkinson's And Zoledronic Acid
- Smoking Cessation With Varenicline in Schizophrenia: Antipsychotic-Induced Neurological Symptoms as Correlates
- Safety and Efficacy of Droxidopa for Fatigue in Patients With Parkinsonism
- Novel Neuroimage Study in Tauopathies With Parkinsonism
- Safety and Efficacy Study of VY-AADC01 for Advanced Parkinson's Disease
- Effect of Clonazepam on REM Sleep Behavior Disorder in Patients With Parkinsonism
- To Study the Efficacy of Bromocriptine in Patients With Hepatic/Cirrhosis Related Parkinsonism
- 2-(1-{6-[(2-[F-18]Fluoroethyl) (Methyl)Amino]-2-naphthyl} Ethylidene) Malononitrile-PET for in Vivo Diagnose of Tauopathy in Unclassified Parkinsonism
- 18F-DTBZ PET and Multi-modal MRI in the Patients With Vascular Parkinsonism
- Developing a Novel Imaging Biomarker in the Differential Diagnosis of Parkinson's Disease and Parkinsonism
- Establishment of Clinical Basis for Hematopoietic Growth Factors Therapy in Brain Injury
- A Cross-Over, Multi-Center Trial to Evaluate the Diagnostic Efficacy and Safety of [123I]NAV5001 as an Imaging Agent to Aid in the Diagnosis of Parkinsonian Syndromes
- Evaluation of the Diagnostic Efficacy and Safety of [123I]NAV5001 as an Imaging Agent to Aid in the Diagnosis of Parkinsonian Syndromes
- Evaluation of Safety and Tolerability of Fetal Mesencephalic Dopamine Neuronal Precursor Cells for Parkinson's Disease
- The Differential Diagnosis of Parkinson's Disease and Parkinsonism by Positron-emission Tomography
- Development of a Novel 18F-DTBZ PET Imaging as a Biomarker to Monitor Neurodegeneration of PARK6 and PARK8 Parkinsonism
- Incobotulinum Toxin A (Xeomin®) for Troublesome Sialorrhea in Parkinson's Disease (PD)/Parkinsonism
- Incobotulinum Toxin A for Sialorrhea in Parkinson's Disease (PD)/Parkinsonism and Amyotrophic Lateral Sclerosis (ALS)
- A Trial of 18F-AV-133 Positron Emission Tomography (PET) Imaging to Differentiate Subjects With Parkinson's Disease (PD) From Other Movement Disorders
- Open-label, Long-term Safety Extension Study of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias
- Evaluation of the Efficacy and Safety of Modified Release AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias
- DaTSCAN Imaging in Aging and Neurodegenerative Disease
- Evaluation of the Efficacy and Safety of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias
- Davunetide (AL-108) in Predicted Tauopathies - Pilot Study
- Amantadine for Improving Neurologic Symptoms in Ataxia-Telangiectasia
- Acute Effects of Preladenant (SCH 420814) on Dyskinesia and Parkinsonism in Levodopa Treated Participants (P05550)
- Botulinum Toxin for Treatment of Seborrhic Dermatitis in Parkinsonian Patients
- Efficacy and Tolerability of Ramelteon in Patients With Rapid Eye Movement (REM) Behavior Disorder and Parkinsonism
- Two Separate But Identical Studies Evaluating the Safety and Efficacy of ALTROPANE® in the Use of SPECT Imaging for Upper Extremity Tremor
- Study of Preladenant for the Treatment of Antipsychotic Induced Movement Disorders in Participants With Schizophrenia (Study P04628)
- Low Dose Apomorphine and Parkinsonism
- Effects of Coenzyme Q10 in Progressive Supranuclear Palsy (PSP)
- Risperidone and Olanzapine for the Schizophrenic Patients With Neuroleptic-Induced Acute Dystonia or Parkinsonism
- Development of Imaging, Clinical and Biochemical Bio-Markers for Parkinson's Disease
- Imaging and Genetic Biomarkers of Parkinson Disease (PD) Onset and Progression in High-risk Families
- Study of Brain Imaging With Nuclear Technology in Individuals With Parkinsonian Syndrome
- Study of Individuals With Parkinson's Symptoms But in Whom There is Diagnostic Uncertainty
- Study of the Effects of Dopaminergic Medications on Dopamine Transporter Density in Subjects With Parkinson's Disease
- A Study of Brain Imaging With Nuclear Medicine Technology in Individuals With and at Risk for Parkinson's Disease
- Study of the Effects of Dopaminergic Medications on Dopamine Transporter Imaging in Parkinson's Disease
- Treatment of Agitation/Psychosis in Dementia/Parkinsonism (TAP/DAP)